156 results
Page 3 of 8
8-K
EX-99.1
v9g9 op2x2
6 Sep 22
POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
8:11am
424B3
ywe zkjwt9gzxdmf
11 Jul 22
Prospectus supplement
4:32pm
POS AM
xnrnb67u
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
EX-4.6
uwfi6dulrc35np 0t
1 Jul 22
Shelf registration
4:13pm
S-3
rm77tbfwrd h2
1 Jul 22
Shelf registration
4:13pm
S-3
EX-1.2
n1p0lwwhh59ib
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.7
7wxgd7clb myr1wnp
1 Jul 22
Shelf registration
4:13pm
424B3
EX-99.1
x37ter 5f0t6ta7docg
16 May 22
Prospectus supplement
8:27am
8-K
EX-99.1
zwtg 1pk5hi
16 May 22
Other Events
8:20am
424B3
ba8v0rb46105aj6plr
13 May 22
Prospectus supplement
8:18am
DEF 14A
izy6qqzzxtfjrsahpk7
28 Apr 22
Definitive proxy
8:36am
424B3
ykw1 y33clqxdfrmyw36
31 Mar 22
Prospectus supplement
11:42am
POS AM
jjs7k1il0 uit77kv1e3
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
hhasjvdajy 3km5cfose
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am